Create a free Skin Inc. account to continue reading

Reprogramming the Palette: Biotech at the Heart of Sensory Innovation

By modulating olfactory receptors with specific antagonist or agonist molecules, fragrance houses can tailor the bloom and lastingness of a scent within complex chemical bases like laundry detergent or hair care with mathematical accuracy.
By modulating olfactory receptors with specific antagonist or agonist molecules, fragrance houses can tailor the bloom and lastingness of a scent within complex chemical bases like laundry detergent or hair care with mathematical accuracy.
Tamline L/peopleimages.com

The flavor and fragrance industry is undergoing a fundamental transition toward molecular engineering as a key element of the sensory tool box. This represents a restructuring of the palette through advanced biotechnology. Recent strategic moves by Mane and Robertet, alongside coordinated sector-wide manifestos, signal that the industry is moving away from the limitations of nature toward a future of augmented naturality and receptor-level precision.

A primary driver of this evolution is the urgent need for supply chain stability. The traditional model, dependent on volatile botanical harvests and climate-vulnerable regions, is being replaced by bio-based discovery and industrial biomanufacturing. A significant example of this is the strategic partnership between bitBiome, Inc. and Tojo Vikas International Pvt. Ltd. 

By pairing bitBiome’s microbial discovery platform—which reportedly includes the world’s largest microbial sequence database—with Tojo Vikas’ global commercialization muscle, the alliance aims to scale high-value aroma and taste molecules with unprecedented cost efficiency and sustainability.

This push for scale is echoed by the Advanced Biotech for Sustainability (AB4S) coalition, which includes heavyweights like L'Oréal, BAS and Evonik. The group's 2026 report, The Molecule Manifesto, identifies a $1.1 trillion market opportunity by 2040 and highlights four priority molecular families for immediate industrial scaling: terpenes, peptides, non-catalytic proteins and hydroxy acids. Terpenes alone, such as patchoulol and nootkatone, represent a $7–12 billion market where biotech offers built-in stereocontrol and natural-identical labeling, finally decoupling the industry from the unpredictability of the field.

Beyond just securing supply, the industry is racing to decode the very biology of human perception. Mane’s January 2026 acquisition of ChemoSensoryx marks a pivot toward bottom-up biotech. Rather than relying solely on the artistic intuition of a perfumer or flavorist, Mane is now integrating a platform capable of individually expressing the full range of human chemosensory receptors—specifically G protein-coupled receptors (GPCRs)—in dedicated cell lines. This allows researchers to generate a detailed olfactogram for any compound, mapping exactly how it interacts with olfactory, gustatory and trigeminal pathways.

This receptor-level screening is transforming flavor creation, particularly in taste modulation. By understanding the molecular mechanisms behind sweetness, bitterness and umami, Mane can now identify new agonists and antagonists to block undesirable off-notes or amplify targeted sensory effects. This scientific depth enables the discovery of enhancers that can precisely tune sensations like kokumi or saltiness, creating more intentional and efficient sensory experiences.

The same precision is being applied to functional perfumery. While aesthetic appeal remains central, biotech now allows for the design of fragrances that trigger specific neurological, emotional or physiological responses. By modulating olfactory receptors with specific antagonist or agonist molecules, fragrance houses can tailor the bloom and lastingness of a scent within complex chemical bases like laundry detergent or hair care with mathematical accuracy. This technology even extends to the trigeminal system, where researchers are developing compounds to selectively modulate ion channels like TRPM8 and TRPA1 to deliver longer-lasting freshness or precisely tuned burn and tingle in oral care and beverages.

The move toward lab-grown ingredients is also taking center stage in the topical beauty and health sectors. Robertet’s strategic investment in Aethera Biotech marks its official entry into the biotech topical cosmetic active sector, establishing a center of excellence for what the company calls augmented naturality. The centerpiece of this venture is Aethera’s multi-patented CROP (Controlled Release of Optimized Plants) platform. This technology uses in vitro plant cell cultures to produce natural phyto-complexes in highly controlled environments.

The CROP platform represents a leap in sustainability and security. By utilizing cell multiplication instead of traditional agricultural methods, Robertet can secure the production of natural extracts regardless of climatic volatility or geopolitical uncertainty. This process significantly reduces the environmental footprint of production while ensuring a consistent supply of high-value active ingredients for global distribution.

Where the industry goes next is a landscape where the intangible—scent and taste—is made increasingly measurable and programmable. The combination of predictive sensory modeling, high-throughput bioassays and plant cell cultures means that the next generation of flavors and fragrances will be more sustainable, more functional and more closely aligned with human biology than ever before. 

More in Home